Institutional Ownership Silence Therapeutics PLC (SLN)
This table provides information about the institutional ownership of Silence Therapeutics PLC (SLN). We have compiled data on the 68 institutions that hold shares in the stock, with a total of 26.5 Million shares, which have been reported (via 13F filing form) to have a value of $430 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Tcg Crossover Management, LLC
Palo Alto, CA |
Aug 14, 2024 Q2 2024 |
3,295,350
shares
|
$53.4 Million
9.38% of portfolio
|
Q1 2024
Added 56.56%
|
|
Siren, L.L.C.
New York, NY |
Nov 13, 2024 Q3 2024 |
2,831,770
shares
|
$45.9 Million
2.57% of portfolio
|
Q3 2024
New holding
|
|
Lombard Odier Asset Management (Usa) Corp
New York, NY |
Aug 14, 2024 Q2 2024 |
2,405,998
shares
|
$39 Million
3.46% of portfolio
|
Q2 2024
Added 0.72%
|
|
Redmile Group, LLC
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
2,014,296
shares
|
$32.7 Million
2.5% of portfolio
|
Q2 2024
Reduced 0.66%
|
|
Logos Global Management LP
San Francisco, CA |
Aug 27, 2024 Q2 2024 |
1,476,061
shares
|
$23.9 Million
2.63% of portfolio
|
Q1 2024
Added 269.02%
|
|
Deep Track Capital, LP
Greenwich, CT |
Aug 14, 2024 Q2 2024 |
1,359,745
shares
|
$22 Million
0.85% of portfolio
|
Q2 2024
Reduced 17.28%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 15, 2024 Q2 2024 |
1,148,591
shares
|
$18.6 Million
1.29% of portfolio
|
Q1 2024
Added 30.35%
|
|
Vivo Capital, LLC
Palo Alto, CA |
Nov 13, 2024 Q3 2024 |
1,105,454
shares
|
$17.9 Million
2.94% of portfolio
|
Q1 2024
Added 116.67%
|
|
Nextech Invest Ag
|
Aug 14, 2024 Q2 2024 |
952,400
shares
|
$15.4 Million
3.41% of portfolio
|
Q1 2024
New holding
|
|
Polar Capital Holdings PLC
London, X0 |
Aug 14, 2024 Q2 2024 |
940,164
shares
|
$15.2 Million
0.11% of portfolio
|
Q2 2024
Added 88.03%
|
|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2024 Q2 2024 |
818,978
shares
|
$13.3 Million
0.01% of portfolio
|
Q2 2024
Added 30.86%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2024 Q2 2024 |
782,941
shares
|
$12.7 Million
0.01% of portfolio
|
Q2 2024
Added 91.23%
|
|
Cormorant Asset Management, LP
Boston, MA |
Aug 14, 2024 Q2 2024 |
625,000
shares
|
$10.1 Million
0.91% of portfolio
|
Q1 2024
New holding
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2024 Q2 2024 |
600,000
shares
|
$9.73 Million
0.02% of portfolio
|
Q1 2024
New holding
|
|
Ikarian Capital, LLC
Dallas, TX |
Aug 14, 2024 Q2 2024 |
506,665
shares
|
$8.21 Million
3.9% of portfolio
|
Q2 2024
New holding
|
|
Aquilo Capital Management, LLC
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
500,214
shares
|
$8.11 Million
9.5% of portfolio
|
Q2 2024
Reduced 12.89%
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
476,200
shares
|
$7.72 Million
4.23% of portfolio
|
Q1 2024
New holding
|
|
Stanley Druckenmiller
Duquesne Family Office LLC | New York, Ny
|
Aug 14, 2024 Q2 2024 |
387,400
shares
|
$6.28 Million
0.25% of portfolio
|
Q1 2024
New holding
|
|
Mangrove Partners
New York, NY |
Aug 14, 2024 Q2 2024 |
385,408
shares
|
$6.25 Million
0.82% of portfolio
|
Q1 2024
New holding
|
|
Sg Americas Securities, LLC
|
Oct 03, 2024 Q3 2024 |
343,190
shares
|
$5.56 Million
0.02% of portfolio
|
Q3 2024
Reduced -0.0%
|
|
Exodus Point Capital Management, LP
New York, NY |
Nov 12, 2024 Q3 2024 |
338,681
shares
|
$5.49 Million
0.04% of portfolio
|
Q3 2024
New holding
|
|
Morgan Stanley
New York, NY |
Oct 17, 2024 Q2 2024 |
303,993
shares
|
$4.93 Million
0.0% of portfolio
|
Q2 2024
Added 25.22%
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Aug 14, 2024 Q2 2024 |
289,841
shares
|
$4.7 Million
0.81% of portfolio
|
Q2 2024
Added 18.56%
|
|
Cantor Fitzgerald, L. P.
New York, NY |
Aug 14, 2024 Q2 2024 |
247,966
shares
|
$4.02 Million
0.68% of portfolio
|
Q2 2024
Added 139.62%
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Aug 20, 2024 Q2 2024 |
200,000
shares
|
$3.24 Million
0.25% of portfolio
|
Q1 2024
New holding
|